← Evidence map

ArticleCancer cell international2025

Correction: The molecular subtyping and precision medicine in triple-negative breast cancer--- based on Fudan TNBC classification.

Lijuan Weng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40307850